Costello Medical
Costello Medical is a privately held firm founded in 2008 and headquartered in Cambridge, United Kingdom. It provides medical communications and health economics services to pharmaceutical, biotechnology, and medical device clients, with 251-500 employees.
- Company typePrivate
- Founded2008
- HeadquartersCambridge, United Kingdom
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Costello Medical does
Costello Medical is a privately held firm founded in 2008 and headquartered in Cambridge, United Kingdom. The company provides medical communications and health economics services, operating in the life sciences support sector. Its clients are pharmaceutical, biotechnology, and medical device organizations that require specialized assistance with scientific publications, medical affairs communications, payer-facing evidence development, and health economic modeling. With 251-500 employees, the firm sits in the mid-tier of the global medical communications and HEOR services market by headcount, and it is privately held with no public listing.
The firm's service offering spans two complementary disciplines. Medical communications typically encompasses scientific writing, peer-reviewed manuscript development, congress materials, and medical affairs content. Health economics and outcomes research (HEOR) covers evidence synthesis, health economic modeling, and value communication to reimbursement stakeholders. No proprietary technology platforms, patents, software products, AI/ML tools, technology integrations, certifications, or regulatory clearances are disclosed in the available source material. The company has no public app, API, or SDK presence, and no awards, partnerships, or alliance arrangements are recorded.
The business model is consistent with professional services — fee-for-service or project-based engagements sold to life sciences sponsors — though specific pricing models, contract structures, deal sizes, and revenue mix are not disclosed. The firm is privately held with no public listing, no disclosed funding rounds, no subsidiaries, and no investor information in the input material. There is no information on ownership structure, parent company, shareholders, or management team. Geographic markets served, named customer logos, and segment breakdown are not documented, constraining granular business model inference and limiting visibility into the company's commercial positioning.
Costello Medical firmographics
Firmographics- Name
- Costello Medical
- Website
- https://costellomedical.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Costello Medical is a privately held firm founded in 2008 and headquartered in Cambridge, United Kingdom. It provides medical communications and health economics services to pharmaceutical, biotechnology, and medical device clients, with 251-500 employees.
- Ownership category
- akta.pro rank
Where Costello Medical is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Costello Medical business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Costello Medical product offering
Product offeringCore offering
Costello Medical provides medical communications and health economic services to pharmaceutical, biotechnology, and medical device clients. The company supports clients across the product lifecycle with services spanning medical writing, evidence generation, and health economics, delivered from its base in Cambridge, United Kingdom.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Communications
- Health Economics Services
Companies that use Costello Medical
Customer profileIdeal customer profiles1 record
Costello Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Costello Medical partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Costello Medical competitors and assessment
Company assessmentDirect peers
- OPEN Health Group: PE-backed global medical communications and HEOR platform combining medcomms, market access, and real-world evidence. Most directly comparable to Costello Medical given overlapping service lines and similar client base in pharma/biotech.
- Fishawack Group: Medical communications agency offering scientific publications, medical affairs, and HEOR services to global pharma. Closely comparable in service mix, scale, and customer profile to Costello Medical.
- Envision Pharma Group: Independent medcomms and HEOR specialist serving global pharma, owned by GHO Capital. Comparable offering across publications, medical affairs, and health economics consulting.
- Ashfield Health (Inizio): Part of Inizio, the medical communications and advisory arm of a major PE-backed healthcare services platform. Direct competitor in medcomms, market access, and HEOR for global pharma clients.
- Cello Health: UK-based healthcare consulting and medcomms firm. Comparable in geographic base, service offering (including HEOR/market access), and customer focus on global pharma.
Broad incumbents
- McCann Health: Global advertising/communications network with significant medical communications and health economics practices. Larger and broader than Costello Medical, but overlapping in scientific storytelling and HEOR work.
- Publicis Health: Global health-focused communications network within Publicis Groupe. Competes with Costello Medical on medcomms and market access engagements as part of a much wider creative and commercial portfolio.
- Syneos Health Communications: Communications arm of large CRO offering medcomms, publications, and HEOR as part of broader clinical and commercial services. Much larger and broader than Costello Medical but overlaps in core medcomms offerings.
- ICON plc: Global CRO with growing medical communications and HEOR capabilities. Broad incumbent serving many of the same pharma clients from a much larger platform.
Emerging players
- Lumanity: PE-backed specialist combining HEOR, market access, and medcomms for pharma and biotech. Smaller and more focused than the largest incumbents but overlapping significantly with Costello Medical's service mix.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
Costello Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Costello Medical leadership team
Management profileNumber of profiles
Profiles1 record
Costello Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Costello Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Costello Medical
What does Costello Medical do?
Costello Medical provides medical communications and health economic services to pharmaceutical, biotechnology, and medical device clients. The company supports clients across the product lifecycle with services spanning medical writing, evidence generation, and health economics, delivered from its base in Cambridge, United Kingdom.
When was Costello Medical founded?
Costello Medical was founded in 2008. It employs 251 to 500 people.
Where is Costello Medical based?
Costello Medical is headquartered in Cambridge, United Kingdom, in the Europe region.
Who are Costello Medical's main competitors?
Direct peers on record are OPEN Health Group, Fishawack Group, Envision Pharma Group, Ashfield Health (Inizio) and Cello Health. Broad incumbents are McCann Health, Publicis Health, Syneos Health Communications and ICON plc. Lumanity is listed as an emerging player.
Does Costello Medical have an API?
No public API is recorded for Costello Medical.